Track market-moving stories before they get noisy

On June 04, 2026, Cheniere Energy Partners LP CQP shares rose 3.7% to a current price of $64.36. This price movement occurs within a 52-week range of $49.53 to $70.64, reflecting a notable increase year-to-date of 23.6% and a 1-year growth of 16.4%.

GF Value™ verdict: Current price is $64.36, which is 4.2% above the GF Value™ estimate of $61.75.GF Score™: 77/100, indicating an above-average rating relative to other stocks.Notable signal: There have been no insider transactions in the last 3 months. Is CQP Overvalued or Undervalued? Based on the GF Value™ estimate, Cheniere Energy Partners LP appears to be slightly overvalued, trading at 4.2% above its intrinsic value of $61.75. This suggests that there may be limited margin for safety at the current price point, as investors might be paying a premium compared to the calculated fair value. The GF Valuation label classifies the stock as fairly valued, which indicates that its current trading price is close to what is deemed reasonable based on its fundamentals.

When a stock is considered overvalued, it carries a risk that the price could correct if market sentiment shifts or if the company's performance does not meet investor expectations. Conversely, if an investor believes in the company's future growth potential, they may see an opportunity despite the current overvaluation. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

How Does CQP's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 15.0x 13.4x Forward P/E 15.8x N/A Cheniere Energy Partners LP's current P/E (TTM) of 15.0x is notably higher than its 5-year median P/E of 13.4x, reflecting a 12% premium. Additionally, the forward P/E of 15.8x also suggests that the stock is trading above its historical valuation metrics. This P/E analysis aligns with the GF Value™ verdict of the stock being overvalued, as the elevated P/E ratios indicate that investors are currently paying more for each dollar of earnings compared to historical averages.

What Does CQP's GF Score™ Tell Us? Metric Rating GF Score™ 77/100 Financial Strength 3/10 Profitability 8/10 Growth 5/10 Valuation 9/10 Momentum 6/10 The GF Score™ evaluates Cheniere Energy Partners LP at 77/100, indicating a solid performance across key aspects. The strongest area is profitability, rated at 8/10, suggesting that the company is effectively generating profits relative to its revenues. Conversely, financial strength is the weakest area, rated at only 3/10, which may highlight potential risks related to liquidity or debt levels. Overall, the score reflects a balanced assessment, with strengths in profitability and valuation but notable weaknesses in financial stability.

What Are Insiders Doing with CQP Stock? There have been no insider transactions in the last 3 months for Cheniere Energy Partners LP. This lack of activity may suggest that insiders are not currently making significant moves, which could indicate a neutral outlook on the stock from those with the most intimate knowledge of the company's operations.

What This Means for Investors Cheniere Energy Partners LP is currently considered overvalued based on the GF Value™ estimate, trading at a price that exceeds its intrinsic value. While the company exhibits strong profitability and a respectable GF Score™, the elevated valuation metrics highlight a potential risk for current investors if market conditions change.

For the complete analysis, visit the Cheniere Energy Partners LP CQP stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is CQP's GF Score™?

The GF Score™ for Cheniere Energy Partners LP is 77/100, indicating an above-average rating that suggests a strong potential for long-term returns.

Is CQP overvalued or undervalued?

CQP is considered overvalued, trading 4.2% above its GF Value™ estimate of $61.75.

What is CQP's P/E ratio?

CQP's current P/E ratio is 15.0x, which is 12% above its 5-year median of 13.4x, indicating that the stock is trading at a higher valuation compared to its historical levels.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

OLN324 demonstrated meaningfully faster and greater improvements in anatomic outcomes in DME and numerically greater vision gains sustained through 20 weeks with fewer retreatments as compared to faricimab New anatomic data demonstrates OLN324 achieves faster, greater, and more durable reductions in wAMD pigment epithelial detachment (PED) thickness versus faricimab Ollin and Innovent Biologics advancing OLN324 into global Phase 3 studies in DME and wAMD in 2026 , /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported final, 20-week study completion data from its randomized, head-to-head Phase 1b JADE clinical study comparing OLN324(Innovent R&D code IBI324) , a higher-potency, smaller-format, higher-molar dose VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). Final results released include favorable durability data for OLN324 compared to faricimab and new anatomic data showing faster, greater, and more durable control of wAMD pigment epithelial detachments (PEDs) with OLN324.

Topline data from the Week 12 primary endpoint readout, previously announced in January 2026 and presented at the Angiogenesis, Exudation, and Degeneration Symposium in February 2026, demonstrated OLN324, compared to faricimab, delivered superior anatomic outcomes in DME, including faster and greater retinal drying and more patients achieving absence of DME; equivalent retinal drying compared to faricimab in wAMD; rapid and sustained gains in vision in both DME and wAMD that were numerically better than faricimab; and had a favorable safety profile with no cases of intraocular inflammation. 

Final 20-Week Study Completion Data Highlights

The JADE trial, which enrolled 164 U.S. patients with either DME or wAMD, all patients initially received three monthly doses of OLN324 or faricimab. Thereafter, they were followed for an additional 12 weeks off treatment, during which they could be retreated based on protocol-specified criteria for disease recurrence that were the same for all groups.

At the final study visit at Week 20, 12 weeks after the last mandatory dose, DME patients treated with OLN324 continued to demonstrate greater retinal drying compared to those treated with faricimab, measured as mean change in central subfield thickness on optical coherence tomography, along with sustained vision gains that were numerically greater for OLN324 4 mg.

These improved efficacy outcomes were achieved with fewer retreatments compared to faricimab. 93% of DME patients randomized to OLN324 4 mg completed 12 weeks of follow-up without retreatment, versus 89% of patients randomized to faricimab.

In wAMD, the rapid and comparable improvements in retinal drying (mean change in OCT CST) observed from Day 1 to Week 12 with OLN324 and faricimab were sustained through Week 20. Patients treated with OLN324 experienced numerically greater vision gains than patients treated with faricimab; the BCVA improvements continued to separate between groups from Weeks 12 to 20, with a mean +2.2 letter advantage observed over faricimab for OLN324 4 mg at Week 20.

82% of OLN324 4 mg patients completed 12 weeks of follow-up without retreatment, compared with 81% of faricimab patients.

OLN324 continued to demonstrate a favorable safety profile, with zero cases of intraocular inflammation observed through the entirety of the study, compared with one case in a faricimab-treated patient. There were no cases of retinal vasculitis or occlusive retinal vasculitis with OLN324.

"These new JADE study data further strengthen the differentiated profile of OLN324, highlighting its robust anatomic efficacy and durability across both DME and wAMD. Combined with a favorable safety profile, these results underscore OLN324's potential to become a first-line treatment option for these vision-threatening diseases," said Jason Ehrlich, M.D., Ph.D., Co-founder and Chief Executive Officer of Ollin Biosciences. "We look forward to advancing OLN324 into global Phase 3 studies in both DME and wAMD later this year. Subject to regulatory communications, we expect the Phase 3 studies to recruit patients from North America, South America, Europe and Japan, and we are actively planning, in partnership with Innovent Biologics, to include China and South Korea."

"We are pleased to see that the latest 20-week data for OLN324 (IBI324) further highlight its differentiated profile and clinical potential," said Dr. Lei Qian, M.D., Ph.D., Chief R&D Officer of General Biomedicine at Innovent Biologics. "We look forward to continuing our close collaboration with Ollin and, following discussions with regulatory authorities, to accelerate the global Phase 3 clinical development of this best-in-disease therapy for retinal diseases."

New Anatomic Results on Pigment Epithelial Detachment (PED) Flattening Highlight Potential for Smaller-Format, Higher-Potency OLN324 to Improve Treatment of wAMD

In newly-available, pre-specified data, wAMD patients in the JADE trial randomized to OLN324 4 mg experienced faster and approximately 50% greater reductions in PED thickness at Week 12 compared to patients randomized to faricimab, measured as mean change in neovascular lesion complex thickness on optical coherence tomography (OCT). Through Week 20, in the off-treatment follow-up period, these improvements were more durable for patients randomized to OLN324 4 mg than faricimab.

"As a field, we've been looking for meaningful advancements that further improve anatomic outcomes in wAMD," said David Eichenbaum, M.D., FASRS, Director of Research, Retina Vitreous Associates of Florida. "These data suggest that OLN324's more potent Ang2 inhibition and smaller molecular format may translate into breaking through the efficacy ceiling experienced with current treatments and offering a clinically-relevant benefit in PED improvement – the most difficult to treat component of wAMD."

Retinal fluid (intraretinal and subretinal) and PEDs are two hallmark anatomic features of wAMD. PEDs are present in approximately 80% of wAMD patients. Persistent PEDs following anti-VEGF treatment are associated with development of subretinal fibrosis, an important cause of late vision loss in wAMD.

Full details of the final JADE study data are expected to be presented at upcoming medical and scientific conferences.

About the OLN324 JADE Study

JADE is a randomized, head-to-head Phase 1b clinical study comparing OLN324, a next-generation VEGF/Ang2 bispecific antibody, to faricimab (Vabysmo®), in patients with diabetic macular edema (DME) or wet (neovascular) age-related macular degeneration (wAMD). More than 160 patients with wAMD or DME were enrolled at sites in the United States. All patients initially received three monthly doses of either OLN324 2 mg, OLN324 4 mg, or faricimab 6 mg. Patients were evaluated at Weeks 1, 4, 8, 12, 16, and 20 and could be retreated at Weeks 12 or 16 based on protocol-specified retreatment criteria that were the same for all groups. The primary objective was to assess safety and tolerability (through Week 12 and Week 20). Prespecified exploratory efficacy objectives included the evaluation of OLN324 vs faricimab on visual acuity and various retinal anatomic parameters.

About OLN324

Building on the clinical success of intravitreal VEGF/Ang2 inhibition, OLN324 is a next-generation VEGF/Ang2 bispecific antibody engineered with substantially higher Ang2 potency relative to faricimab, increased molar dosing relative to both faricimab and aflibercept (including Eylea HD®), and a smaller protein format. VEGF and Ang2 are central drivers of retinal vascular diseases such as diabetic macular edema (DME) and wet (neovascular) age-related macular degeneration (wAMD), with Ang2 playing a key role in vascular instability, leakage, inflammation, and fibrosis. OLN324 was discovered by and is being developed in collaboration with Innovent Biologics (HKEX: 01801; Innovent R&D code: IBI324).

About Diabetic Macular Edema (DME)

Diabetic macular edema, a vision-threatening complication of diabetic eye disease, is a leading cause of vision loss among working-age adults in the developed world. In diabetic macular edema, progressive microvasculature damage, ischemia and microvascular inflammation result in vascular leakage and retinal swelling that compromise vision.

About Wet Age-Related Macular Degeneration (wAMD)

Age-Related Macular Degeneration, a chronic and progressive retinal disease, is the leading cause of vision loss among older adults in the developed world. In wet (or neovascular) AMD, abnormal blood vessels growing beneath the retina leak and bleed, resulting in significant vision impairment.

About Ollin Biosciences

Established in 2023, Ollin BiosciencesTM is a clinical-stage biopharmaceutical company dedicated to acquiring and developing best-in-disease therapies for vision-threatening diseases. With a differentiated pipeline, world-class team, and strong investor syndicate, Ollin is redefining what's possible in ophthalmology. For more information, please visit us at www.ollin.bio and follow us on LinkedIn and X.

About Innovent

Innovent is a leading biopharmaceutical company founded in 2011 with the mission to empower patients worldwide with affordable, high-quality biopharmaceuticals. The company discovers, develops, manufactures and commercializes innovative medicines that target some of the most intractable diseases. Its pioneering therapies treat cancer, cardiovascular and metabolic, autoimmune and eye diseases. Innovent has launched 18 products in the market. It has 4 assets in Phase 3 or pivotal clinical trials and 15 more molecules in early clinical stage. Innovent partners with over 30 global healthcare companies, including Lilly, Sanofi, Incyte, LG Chem and MD Anderson Cancer Center.

Guided by the motto, "Start with Integrity, Succeed through Action" Innovent maintains the highest standard of industry practices and works collaboratively to advance the biopharmaceutical industry so that first-rate pharmaceutical drugs can become widely accessible. For more information, visit www.innoventbio.com, or follow Innovent on Facebook and LinkedIn.

Disclaimer: Innovent does not recommend any off-label usage.

Vabysmo® is a registered trademark of Genentech, Inc.; Eylea® and Eylea HD® are registered trademarks of Regeneron Pharmaceuticals, Inc.

Forward-looking statement

This news release may contain certain forward-looking statements that are, by their nature, subject to significant risks and uncertainties. The words "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Innovent Biologics ("Innovent"), are intended to identify certain of such forward-looking statements. The Company does not intend to update these forward-looking statements regularly.

These forward-looking statements are based on the existing beliefs, assumptions, expectations, estimates, projections and understandings of the management of the Company with respect to future events at the time these statements are made. These statements are not a guarantee of future developments and are subject to risks, uncertainties and other factors, some of which are beyond the Company's control and are difficult to predict. Consequently, actual results may differ materially from information contained in the forward-looking statements as a result of future changes or developments in our business, the Company's competitive environment and political, economic, legal and social conditions.

The Company, the Directors and the employees of the Company assume (a) no obligation to correct or update the forward-looking statements contained in this site; and (b) no liability in the event that any of the forward-looking statements does not materialise or turn out to be incorrect.

SOURCE Innovent Biologics

Olin remains a buy as Middle East conflict tightens global petrochemical supply, supporting US-centric producers and improving pricing power. OLN's Q1 likely marks the bottom, with Q2 expected to benefit from lower US natural gas prices and improved margins, especially in Chlor Alkali. Despite weak construction demand, supply disruptions and cost tailwinds should drive at least $150M free cash flow in 2026, with further upside possible.

Highlights

First quarter 2026 net loss of ($83.0) million, or ($0.73) per diluted share Quarterly adjusted EBITDA of $86.2 million , /PRNewswire/ -- Olin Corporation (NYSE: OLN) announced financial results for the first quarter ended March 31, 2026. First quarter 2026 reported net loss was ($83.0) million, or ($0.73) per diluted share, which compares to first quarter 2025 reported net income of $1.4 million, or $0.01 per diluted share. First quarter 2026 adjusted EBITDA of $86.2 million excludes depreciation and amortization expense of $117.2 million, restructuring charges of $9.1 million and legacy litigation charges of $36.1 million. First quarter 2025 adjusted EBITDA was $185.6 million. Sales in the first quarter 2026 were $1,583.0 million, compared to $1,644.2 million in the first quarter 2025.

Ken Lane, President and Chief Executive Officer, said, "During the first quarter, the Olin team delivered sequential improvement in adjusted EBITDA. Our Chlor Alkali Products and Vinyls business benefited from favorable operating cost performance driven by our Beyond250 structural cost actions and lower than expected planned maintenance turnaround expenses. Our Epoxy business returned to positive adjusted EBITDA underpinned by growth in its European business, supported by structurally improved costs at our Stade, Germany facility. Winchester's sequential improvement was driven by actions taken late last year to accelerate channel inventory destocking, as well as improving demand and pricing measures implemented to offset commodity metals and raw materials cost inflation.

"Late in the first quarter, the Iran conflict began to impact trade flows and to increase raw material and feedstock costs. As global supply shortages persist into the second quarter and potentially beyond, our advantaged North American asset base positions us to reliably serve our customers.

"Looking ahead, our Chemicals businesses are expected to deliver sequential earnings improvement driven by seasonally stronger demand and improved pricing, particularly for ethylene dichloride, caustic soda, and epoxy resins. In our Winchester business, improving commercial and military demand are expected to support sequential earnings growth. Overall, second quarter 2026 adjusted EBITDA is forecast to be in the range of $160 million to $200 million," Lane concluded.

SEGMENT REPORTING

Olin defines segment earnings as income (loss) before interest expense, interest income, other operating income (expense), non-operating pension income, other income, and income taxes.

CHLOR ALKALI PRODUCTS AND VINYLS

Chlor Alkali Products and Vinyls sales for the first quarter 2026 were $756.9 million, compared to $924.5 million in the first quarter 2025. The decrease in sales was due to lower volumes, primarily resulting from lower trading volumes associated with Blue Water Alliance, and lower pricing. The Blue Water Alliance joint venture concluded operations at the end of 2025. First quarter 2026 segment loss was ($44.5) million, compared to segment earnings of $78.3 million in the first quarter 2025. The $122.8 million decrease in segment earnings was primarily due to lower pricing and volumes, higher raw material costs, primarily natural gas and electrical power costs, and higher planned maintenance turnaround expenses, partially offset by lower operating costs. Segment results included $36.1 million in legacy litigation costs. Chlor Alkali Products and Vinyls first quarter 2026 results included depreciation and amortization expense of $93.2 million compared to $107.2 million in the first quarter 2025.

EPOXY

Epoxy sales for the first quarter 2026 were $355.6 million, compared to $331.7 million in the first quarter 2025. First quarter 2026 segment loss was ($2.9) million, compared to segment loss of ($28.4) million in the first quarter 2025. The $25.5 million increase in segment results was primarily due to lower operating costs and higher volumes. Product margins were slightly lower year over year. Epoxy first quarter 2026 results included depreciation and amortization expense of $11.9 million compared to $12.8 million in the first quarter 2025.

WINCHESTER

Winchester sales for the first quarter 2026 were $470.5 million, compared to $388.0 million in the first quarter 2025. The increase in sales was primarily due to higher military project revenue and military sales, and higher commercial ammunition sales. First quarter 2026 segment earnings were $15.2 million, compared to $22.8 million in the first quarter 2025. The $7.6 million decrease in segment earnings was primarily due to higher raw material costs, primarily commodity metal costs, and higher operating costs, partially offset by higher commercial ammunition pricing and higher military project revenue. Winchester first quarter 2026 results included depreciation and amortization expense of $8.9 million compared to $9.5 million in the first quarter 2025.

CORPORATE AND OTHER COSTS

Other corporate and unallocated costs in the first quarter of 2026 increased $13.2 million compared to the first quarter 2025 primarily due to higher incentive costs, primarily mark-to-market on stock-based compensation, and an unfavorable impact from foreign currency.

LIQUIDITY AND DIVIDENDS

The cash balance on March 31, 2026, was $192.2 million. Olin ended the first quarter 2026 with net debt of approximately $2.8 billion and a net debt to adjusted EBITDA ratio of 5.1 times. On March 31, 2026, Olin had available liquidity of approximately $1.3 billion, including unrestricted access to the undrawn portion of its revolving credit facility. Working capital increased $56.8 million in the first quarter 2026 due to normal seasonality tempered by a disciplined cash management approach.

On April 29, 2026, Olin's Board of Directors declared a dividend of $0.20 on each share of Olin common stock.  The dividend is payable on June 12, 2026, to shareholders of record at the close of business on May 14, 2026.  This will be the 398th consecutive quarterly dividend to be paid by the Company.

CONFERENCE CALL INFORMATION

Olin senior management will host a conference call to discuss first quarter 2026 financial results at 9:00 a.m. Eastern Time on Friday, May 8, 2026. Remarks will be followed by a question-and-answer session. Associated slides and the conference call webcast are accessible via Olin's website, www.olin.com, under the first quarter conference call icon. An archived replay of the webcast will also be available in the Investor Relations section of Olin's website beginning at 12:00 p.m. Eastern Time. A final transcript of the call will be posted the next business day.

COMPANY DESCRIPTION

Olin Corporation is a leading vertically integrated global manufacturer and distributor of chemical products and a leading U.S. manufacturer of ammunition. The chemical products produced include chlorine and caustic soda, vinyls, epoxies, chlorinated organics, bleach, hydrogen, and hydrochloric acid. Winchester's principal manufacturing facilities produce and distribute sporting ammunition, law enforcement ammunition, reloading components, small caliber military ammunition and components, industrial cartridges, and clay targets, along with contracted U.S. military project revenue.

Visit www.olin.com for more information on Olin Corporation.

FORWARD-LOOKING STATEMENTS

This communication includes forward-looking statements. These statements relate to analyses and other information that are based on management's beliefs, certain assumptions made by management, forecasts of future results, and current expectations, estimates and projections about the markets and economy in which we and our various segments operate. The statements contained in this communication that are not statements of historical fact may include forward-looking statements that involve a number of risks and uncertainties.

We have used the words "anticipate," "intend," "may," "expect," "believe," "should," "plan," "outlook," "project," "estimate," "forecast," "optimistic," "target," and variations of such words and similar expressions in this communication to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks, uncertainties, and assumptions, which are difficult to predict and many of which are beyond our control. Therefore, actual outcomes and results may differ materially from those matters expressed or implied in such forward-looking statements. We undertake no obligation to update publicly any forward-looking statements, whether as a result of future events, new information or otherwise. The payment of cash dividends is subject to the discretion of our Board of Directors and will be determined in light of then-current conditions, including our earnings, our operations, our financial conditions, our capital requirements and other factors deemed relevant by our Board of Directors. In the future, our Board of Directors may change our dividend policy, including the frequency or amount of any dividend, in light of then-existing conditions.

The risks, uncertainties and assumptions involved in our forward-looking statements, many of which are discussed in more detail in our filings with the SEC, including without limitation the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2025, and our Quarterly Reports on Form 10-Q and other reports furnished or filed with the SEC, include, but are not limited to, the following:

Business, Industry and Operational Risks

sensitivity to economic, business and market conditions in the United States and overseas, including economic instability or a downturn in the sectors served by us; declines in average selling prices for our products and the supply/demand balance for our products, including the impact of excess industry capacity or an imbalance in demand for our chlor alkali products; unsuccessful execution of our operating model, which prioritizes Electrochemical Unit (ECU) margins over sales volumes; failure to control costs and inflation impacts or failure to achieve targeted cost reductions; availability of and/or higher-than-expected costs of raw material, energy, transportation, and/or logistics; our reliance on a limited number of suppliers for specified feedstock and services and our reliance on third-party transportation; the occurrence of unexpected manufacturing interruptions and outages, including those occurring as a result of labor disruptions and production hazards; exposure to physical risks associated with climate-related events or increased severity and frequency of severe weather events; the failure or an interruption, including cyber-attacks, of our information technology systems; risks associated with our international sales and operations, including economic, political or regulatory changes; weak industry conditions affecting our ability to comply with the financial maintenance covenants in our debt agreements; our indebtedness and debt service obligations; failure to identify, attract, develop, retain and motivate qualified employees throughout the organization and ability to manage executive officer and other key senior management transitions; adverse conditions in the credit and capital markets, limiting or preventing our ability to borrow or raise capital; our inability to complete future acquisitions or joint venture transactions or successfully integrate them into our business; the effects of any declines in global equity markets on asset values and any declines in interest rates or other significant assumptions used to value the liabilities in, and funding of, our pension plans; our long-range plan assumptions not being realized, causing a non-cash impairment charge of long-lived assets; Legal, Environmental and Regulatory Risks

changes in, or failure to comply with, legislation or government regulations or policies, including changes regarding our ability to manufacture or use certain products and changes within the international markets in which we operate; new regulations or public policy changes regarding the transportation of hazardous chemicals and the security of chemical manufacturing facilities; unexpected outcomes from legal or regulatory claims and proceedings; costs and other expenditures in excess of those projected for environmental investigation and remediation or other legal proceedings; and various risks associated with our Lake City U.S. Army Ammunition Plant contract and performance under other governmental contracts. All of our forward-looking statements should be considered in light of these factors. In addition, other risks and uncertainties not presently known to us or that we consider immaterial could affect the accuracy of our forward-looking statements.

2026-06

Olin Corporation

Consolidated Statements of Operations (a)

Three Months Ended
March 31,

($ in millions, except per share amounts)

2026

2025

Sales

$   1,583.0

$   1,644.2

Operating Expenses:

Cost of Goods Sold

1,507.2

1,495.5

Selling and Administrative

145.0

101.0

Restructuring Charges

9.1

4.0

Operating (Loss) Income

(78.3)

43.7

Losses of Non-consolidated Affiliates

(1.4)

—

Interest Expense

(43.2)

(48.5)

Interest Income

1.1

1.2

Non-operating Pension Income

3.5

5.7

Income (Loss) before Taxes

(118.3)

2.1

Income Tax (Benefit) Provision

(35.3)

0.9

Net (Loss) Income

(83.0)

1.2

Net Loss Attributable to Noncontrolling Interests

—

(0.2)

Net (Loss) Income Attributable to Olin Corporation

$      (83.0)

$          1.4

Net (Loss) Income Attributable to Olin Corporation per Common Share:

Basic

$      (0.73)

$        0.01

Diluted

$      (0.73)

$        0.01

Dividends per Common Share

$        0.20

$        0.20

Average Common Shares Outstanding - Basic

113.8

115.3

Average Common Shares Outstanding - Diluted

113.8

116.6

(a)     Unaudited.

Olin Corporation

Segment Information (a)

Three Months Ended
March 31,

($ in millions)

2026

2025

Sales:

Chlor Alkali Products and Vinyls

$      756.9

$      924.5

Epoxy

355.6

331.7

Winchester

470.5

388.0

Total Sales

$   1,583.0

$   1,644.2

Income (Loss) before Taxes:

Chlor Alkali Products and Vinyls

$      (44.5)

$        78.3

Epoxy

(2.9)

(28.4)

Winchester

15.2

22.8

Corporate/Other:

      Environmental Expense

(5.2)

(5.0)

      Other Corporate and Unallocated Costs

(33.2)

(20.0)

    Restructuring Charges

(9.1)

(4.0)

Interest Expense

(43.2)

(48.5)

Interest Income

1.1

1.2

Non-operating Pension Income

3.5

5.7

Income (Loss) before Taxes

$    (118.3)

$          2.1

(a)     Unaudited.

Olin Corporation

Consolidated Balance Sheets (a)

March 31,

December 31,

March 31,

($ in millions, except per share data)

2026

2025

2025

Assets:

  Cash and Cash Equivalents

$            192.2

$            167.6

$            174.0

  Accounts Receivable, Net

915.4

844.5

1,107.3

  Income Taxes Receivable

58.7

66.6

15.8

  Inventories, Net

827.2

784.5

875.2

  Other Current Assets

103.2

107.9

79.0

    Total Current Assets

2,096.7

1,971.1

2,251.3

Property, Plant and Equipment (Less Accumulated Depreciation of
$5,565.6, $5,508.7 and $5,291.8)

2,129.3

2,196.9

2,266.5

  Operating Lease Assets, Net

301.7

298.6

289.0

  Deferred Income Taxes

45.4

47.2

54.5

  Other Assets

1,188.2

1,210.0

1,171.6

  Intangibles, Net

164.8

174.4

198.6

  Goodwill

1,427.7

1,427.6

1,423.5

Total Assets

$         7,353.8

$         7,325.8

$         7,655.0

Liabilities and Shareholders' Equity:

  Current Installments of Long-term Debt

$                  —

$            109.7

$              19.2

  Accounts Payable

911.4

806.1

812.0

  Income Taxes Payable

13.1

23.9

116.9

  Current Operating Lease Liabilities

60.5

59.7

62.5

  Accrued Liabilities

558.7

630.1

428.4

    Total Current Liabilities

1,543.7

1,629.5

1,439.0

  Long-term Debt

2,996.1

2,717.6

3,016.6

  Operating Lease Liabilities

254.3

252.5

231.9

  Accrued Pension Liability

198.3

200.9

207.6

  Deferred Income Taxes

280.7

317.6

417.9

  Other Liabilities

346.0

337.1

303.9

Total Liabilities

5,619.1

5,455.2

5,616.9

Commitments and Contingencies

Shareholders' Equity:

Common Stock, $1.00 Par Value Per Share; Authorized 240.0 Shares;
Issued and Outstanding 113.9, 113.6 and 115.1 Shares

113.9

113.6

115.1

Additional Paid-in Capital

4.8

—

—

Accumulated Other Comprehensive Loss

(418.4)

(414.5)

(430.6)

Retained Earnings

2,034.0

2,139.8

2,321.5

Olin Corporation's Shareholders' Equity

1,734.3

1,838.9

2,006.0

Noncontrolling Interests

0.4

31.7

32.1

Total Equity

1,734.7

1,870.6

2,038.1

Total Liabilities and Equity

$         7,353.8

$         7,325.8

$         7,655.0

(a)     Unaudited.

Olin Corporation

Consolidated Statements of Cash Flows (a)

Three Months Ended
March 31,

($ in millions)

2026

2025

Operating Activities:

Net (Loss) Income

$      (83.0)

$          1.2

Depreciation and Amortization

117.2

132.2

Losses of Non-consolidated Affiliates

1.4

—

Stock-based Compensation

4.7

4.0

Deferred Income Taxes

(34.3)

(18.2)

Qualified Pension Plan Contributions

(0.3)

(0.1)

Qualified Pension Plan Income

(3.0)

(5.0)

Changes in Assets and Liabilities:

Receivables

(73.9)

(98.2)

Income Taxes Receivable/Payable

(2.8)

(34.0)

Inventories

(44.3)

(43.9)

Other Current Assets

1.5

4.2

Accounts Payable and Accrued Liabilities

62.7

(32.5)

Other Assets

1.5

4.6

Other Noncurrent Liabilities

6.6

1.1

Other Operating Activities

(2.6)

(1.4)

Net Operating Activities

(48.6)

(86.0)

Investing Activities:

Capital Expenditures

(43.7)

(61.4)

Investments in Non-consolidated Affiliates

(0.3)

—

Other Investing Activities

1.0

(1.0)

Net Investing Activities

(43.0)

(62.4)

Financing Activities:

Long-term Debt Borrowings, Net

170.3

199.9

Common Stock Repurchased and Retired

—

(20.2)

Stock Options Exercised

2.1

1.9

Dividends Paid

(22.8)

(23.0)

Distributions to Noncontrolling Interests

(31.3)

—

Debt Issuance Costs

(2.1)

(12.0)

Net Financing Activities

116.2

146.6

Effect of Exchange Rate Changes on Cash and Cash Equivalents

—

0.2

Net Increase (Decrease) in Cash and Cash Equivalents

24.6

(1.6)

Cash and Cash Equivalents, Beginning of Year

167.6

175.6

Cash and Cash Equivalents, End of Period

$      192.2

$      174.0

(a)

Unaudited. 

Olin Corporation

Non-GAAP Financial Measures - Adjusted EBITDA (a)

Olin's definition of Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus 
an add-back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense
(income), restructuring charges (income) and certain other non-recurring items. Adjusted EBITDA is a non-GAAP financial
measure. Management believes that this measure is meaningful to investors as a supplemental financial measure to assess the
financial performance without regard to financing methods, capital structures, taxes or historical cost basis. The use of non-
GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP and
Adjusted EBITDA presented may not be comparable to similarly titled measures of other companies. Reconciliation of forward-
looking non-GAAP financial measures to the most directly comparable GAAP financial measures are omitted from this release
because Olin is unable to provide such reconciliations without the use of unreasonable efforts. This inability results from the
inherent difficulty in forecasting generally and quantifying certain projected amounts that are necessary for such reconciliations.
In particular, sufficient information is not available to calculate certain adjustments required for such reconciliations, including
interest expense (income), income tax provision (benefit), other expense (income) and restructuring charges (income). Because
of our inability to calculate such adjustments, forward-looking net income guidance is also omitted from this release. We expect
these adjustments to have a potentially significant impact on our future GAAP financial results.

Three Months Ended
March 31,

($ in millions)

2026

2025

Reconciliation of Net (Loss) Income to Adjusted EBITDA:

Net (Loss) Income

$         (83.0)

$            1.2

Add Back:

Interest Expense

43.2

48.5

Interest Income

(1.1)

(1.2)

Income Tax (Benefit) Provision

(35.3)

0.9

Depreciation and Amortization

117.2

132.2

EBITDA

41.0

181.6

Add Back:

Restructuring Charges

9.1

4.0

Legacy Litigation Matters

36.1

—

Adjusted EBITDA

$          86.2

$        185.6

(a) Unaudited.

Olin Corporation

Non-GAAP Financial Measures - Net Debt to Adjusted EBITDA (a)

Olin's definition of Net Debt to Adjusted EBITDA is Net Debt divided by Adjusted EBITDA. Net Debt at the end of any
reporting period is defined as the sum of our current installments of long-term debt and long-term debt, less cash and cash
equivalents. Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) is net income (loss) plus an add-
back for depreciation and amortization, interest expense (income), income tax provision (benefit), other expense (income),
restructuring charges (income) and certain other non-recurring items. Net Debt to Adjusted EBITDA is a non-GAAP financial
measure. Management believes that this measure is meaningful to investors as a measure of our ability to manage our
indebtedness. The use of non-GAAP financial measures is not intended to replace any measures of indebtedness or liquidity
determined in accordance with GAAP and Net Debt or Net Debt to Adjusted EBITDA presented may not be comparable to
similarly titled measures of other companies.

March 31,

December 31,

March 31,

($ in millions)

2026

2025

2025

Current Installments of Long-term Debt

$                  —

$            109.7

$              19.2

Long-term Debt

2,996.1

2,717.6

3,016.6

Total Debt

2,996.1

2,827.3

3,035.8

Less: Cash and Cash Equivalents

(192.2)

(167.6)

(174.0)

Net Debt

$         2,803.9

$         2,659.7

$         2,861.8

Trailing Twelve Months Adjusted EBITDA (b)

$            552.4

$            651.8

$            817.4

Net Debt to Adjusted EBITDA

5.1

4.1

3.5

(a)

Unaudited.

(b)

Trailing Twelve Months Adjusted EBITDA as of March 31, 2026 is calculated as the three months ended March 31, 2026 plus
the year ended December 31, 2025 less the three months ended March 31, 2025. Trailing Twelve Months Adjusted EBITDA
as of March 31, 2025 is calculated as the three months ended March 31, 2025 plus the year ended December 31, 2024 less
the three months ended March 31, 2024.

SOURCE Olin Corporation

Olin (OLN - Free Report) came out with a quarterly loss of $0.65 per share versus the Zacks Consensus Estimate of a loss of $0.67. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +3.10%. A quarter ago, it was expected that this chlor-alkali and ammunition producer' would post a loss of $0.58 per share when it actually produced a loss of $0.58, delivering no surprise.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Olin, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $1.58 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 1.11%. This compares to year-ago revenues of $1.64 billion. The company has topped consensus revenue estimates three times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Olin shares have added about 38.3% since the beginning of the year versus the S&P 500's gain of 7.6%.

What's Next for Olin?While Olin has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Olin was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.01 on $1.68 billion in revenues for the coming quarter and -$0.90 on $6.63 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Chemical - Diversified is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the broader Zacks Basic Materials sector, Avino Silver (ASM - Free Report) , is yet to report results for the quarter ended March 2026. The results are expected to be released on May 13.

This company is expected to post quarterly earnings of $0.07 per share in its upcoming report, which represents no change from the year-ago quarter. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

Avino Silver's revenues are expected to be $35.1 million, up 86.3% from the year-ago quarter.

Key Takeaways Olin posted a narrower-than-expected Q1 loss as Winchester sales offset weaker Chemicals demand.OLN's Winchester sales jumped on military projects and stronger commercial ammunition demand.Olin expects Q2 EBITDA of $160M-$200M amid stronger demand and pricing improvements. Olin Corporation (OLN - Free Report) reported a first-quarter 2026 adjusted loss of 65 cents per share, narrower than the Zacks Consensus Estimate of a loss of 67 cents, delivering a 3% earnings surprise.

On a reported basis, the company posted a net loss of $83 million, or 73 cents, versus year-ago net income of $1.4 million, or a penny per share.

Sales were $1,583 million, down 3.7% year over year but ahead of the consensus estimate of $1,565.6 million by 1.1%.

Adjusted EBITDA came in at $86.2 million, with results reflecting weaker Chemicals conditions that were partially offset by stronger Winchester sales.

OLN's Segmental ReviewChlor Alkali Products and Vinyls sales were $756.9 million, down from $924.5 million in the year-ago quarter. The reported figure missed the consensus estimate of $799 million. Olin attributed the decline to lower volumes and pricing, with volumes pressured by reduced trading activity tied to the Blue Water Alliance joint venture, which concluded operations at the end of 2025.

Epoxy sales increased to $355.6 million from $331.7 million, supported by higher volumes. The metric beat the consensus estimate of $349 million. Segment loss was lower due to lower operating costs, even as product margins were slightly down year over year.

Winchester sales rose to $470.5 million from $388 million, driven by higher military project revenues and military sales, along with higher commercial ammunition sales. It outpaced the consensus estimate of $408 million.

OLN's FinancialsOlin ended the quarter with cash and cash equivalents of $192.2 million. Net debt was approximately $2.8 billion. Net cash used in operating activities was $48.6 million in the first quarter, compared with $86 million used in the prior-year quarter. Olin paid $22.8 million in dividends and did not repurchase common stock during the quarter.

OLN's OutlookManagement expects sequential improvement in Chemicals in the second quarter, driven by seasonally stronger demand and improved pricing, particularly for ethylene dichloride, caustic soda and epoxy resins. In Winchester, the company sees improving commercial and military demand supporting sequential earnings growth, alongside pricing measures aimed at offsetting raw material inflation.

Olin guided second-quarter 2026 adjusted EBITDA to a range of $160 million to $200 million. The company also noted that the Iran conflict began impacting trade flows late in the first quarter and lifted raw material and feedstock costs, with global supply shortages potentially persisting into the second quarter and beyond.

Olin’s Price PerformanceShares of Olin have gained 26.2% in the past year, compared with 13.1% rise of the industry.

Image Source: Zacks Investment Research

OLN’s Zacks Rank & Key PicksOLN currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the basic materials space are Idaho Strategic Resources, Inc. (IDR - Free Report) , NioCorp Developments Ltd. (NB - Free Report) and Hawkins, Inc. (HWKN - Free Report) .

Idaho is expected to report first-quarter 2026 results on May 14. The Zacks Consensus Estimate for earnings is pegged at 43 cents per share, indicating 258.33% year-over-year growth. IDR sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here. 

NioCorp is expected to report third-quarter fiscal 2026 results on May 14. The consensus estimate for NB’s loss per share is pegged at 2 cents, indicating 83.33% year-over-year growth. NB presently flaunts a Zacks Rank #1.

Hawkins is scheduled to report fiscal fourth-quarter 2026 results on May 13. The Zacks Consensus Estimate for HWKN’s first-quarter earnings per share is pegged at 77 cents. HWKN carries a Zacks Rank #2 (Buy) at present.

On May 29, 2026, Olin Corp OLN shares fell 3.3% to a current price of $25.87, reflecting a broader trend as the stock has decreased 4.8% over the past month. The price has fluctuated between a 52-week high of $30.46 and a low of $18.08.

GF Value™ verdict: Current price of $25.87 is 43.3% undervalued compared to the GF Value™ of $45.61.GF Score™ of 63/100 indicates an above-average stock performance potential.Most notable signal: Momentum rank of 9/10 suggests strong recent performance despite the current price drop. Is OLN Overvalued or Undervalued? The current price of Olin Corp OLN at $25.87 represents a significant discount to the GF Value™, which estimates the fair value at $45.61. This indicates that the stock is trading at a 43.3% margin of safety. However, the GF Valuation label of "Possible Value Trap, Think Twice" introduces caution. While this undervaluation suggests an opportunity, it also implies that the company's fundamentals might not support a recovery to its intrinsic value. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

Investors should be aware that while the stock appears undervalued, the low financial strength score of 3/10 and a Piotroski F-Score of 4 indicate potential underlying issues that could hinder price recovery. The Altman Z-Score of 1.67 also suggests that the company may be at risk of financial distress, raising concerns about the sustainability of any potential gains.

How Does OLN's Valuation Compare to Its History? MetricCurrentHistorical P/E (TTM)Not Available10.0x Forward P/E188.8xN/A As the current P/E ratio is not available, we cannot compare it directly with the 5-year median P/E of 10.0x. However, the forward P/E of 188.8x indicates that the stock is priced significantly above historical valuation levels. This analysis aligns with the GF Value™ verdict, suggesting that while the stock is currently undervalued based on price, it may be overvalued when taking future earnings expectations into account.

What Does OLN's GF Score™ Tell Us? MetricRating GF Score™63/100 Financial Strength3/10 Profitability5/10 Growth3/10 Valuation4/10 Momentum9/10 The GF Score™ of 63/100 suggests that Olin Corp has potential for above-average performance, primarily driven by its momentum rank of 9/10. However, the financial strength score of 3/10 and growth rank of 3/10 indicate significant weaknesses that could affect long-term performance. The profitability and valuation ranks of 5/10 and 4/10, respectively, suggest that while the company has made some strides in profitability, there are still considerable concerns regarding its valuation metrics.

What Are Insiders Doing with OLN Stock? In the last three months, there have been no insider transactions reported for Olin Corp OLN . This lack of insider activity may suggest uncertainty about the company's future prospects, as typically, insider buying can indicate confidence in the company's performance. The absence of buying or selling signals may also indicate that insiders are taking a wait-and-see approach in light of recent stock performance.

What This Means for Investors Based on the GF Value™ analysis, Olin Corp OLN is currently undervalued, trading at $25.87 compared to an estimated fair value of $45.61. However, investors should approach with caution due to the potential value trap indicated by the GF Valuation label and the concerning financial strength metrics.

For the complete analysis, visit the Olin Corp OLN stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is OLN's GF Score™?

OLN has a GF Score™ of 63/100, suggesting that it has above-average potential for performance based on its key aspects.

Is OLN overvalued or undervalued?

OLN is currently undervalued, with a GF Value™ of $45.61 compared to its current price of $25.87, indicating a 43.3% margin of safety.

What is OLN's P/E ratio?

The current P/E ratio for OLN is not available, but the forward P/E is 188.8x, suggesting that the stock is trading at a premium compared to its historical valuation.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

On June 01, 2026, Microchip Technology Inc MCHP shares fell 3.3% today, currently trading at $91.52. Over the past 52 weeks, the stock has ranged between $48.52 and $105.91, reflecting significant volatility. The recent price decline raises questions about the company's valuation amid its strong performance over the past year.

GF Value™ verdict: Current price of $91.52 is 59.2% above the GF Value™ estimate of $57.48.GF Score™: 76/100, indicating an above-average rating in terms of long-term investment potential.Most notable signal: Insiders sold $51.2M worth of shares in the last 3 months, with no buying activity. Is MCHP Overvalued or Undervalued? Microchip Technology Inc is currently assessed to be significantly overvalued, as indicated by the GF Value™ of $57.48 compared to its current market price of $91.52. This represents a substantial margin of safety that investors may want to consider when evaluating their positions. The GF Valuation label classifies the stock as "Significantly Overvalued," highlighting the risk associated with investing at such elevated price levels. When the market price is substantially above the intrinsic value, it often suggests that the stock may be at risk of correction or increased volatility.

Investors should be cautious when considering shares of MCHP, given the stark contrast between its trading price and the GF Value™ estimate. Such overvaluation can lead to increased risk, as the potential for future price declines remains a concern. GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.

How Does MCHP's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 435.8x 27.2x Forward P/E 29.0x - The current P/E ratio of 435.8x is strikingly above the 5-year median P/E of 27.2x, indicating that the stock is trading at a historically high valuation. Furthermore, the current P/E is 1503% above its 5-year median, suggesting a significant disconnect between price and earnings potential. This P/E analysis aligns with the GF Value™ verdict, confirming that MCHP is overvalued based on its historical performance metrics.

What Does MCHP's GF Score™ Tell Us? Metric Rating GF Score™ 76/100 Financial Strength 5/10 Profitability 6/10 Growth 7/10 Valuation 3/10 Momentum 10/10 The GF Score™ of 76/100 reflects a strong overall rating for Microchip Technology, particularly in growth (7/10) and momentum (10/10). However, the valuation score is notably low at 3/10, which aligns with the overvaluation indicated by the GF Value™. The company’s financial strength rating of 5/10 suggests that while it has some stability, there are areas for improvement. The profitability rank of 6/10 indicates moderately favorable margins, but the valuation concerns overshadow these strengths at present.

What Are Insiders Doing with MCHP Stock? Recent insider activity for Microchip Technology shows that insiders have sold $51.2 million worth of shares over the last three months, with no reported purchases. This pattern suggests a lack of confidence from insiders in the current valuation or future prospects of the company. Insider selling can often be interpreted as a bearish signal, indicating that those closest to the company may believe the stock is overvalued.

The absence of buying activity further reinforces concerns about the stock's valuation and future performance, as insiders typically acquire shares when they believe in the company's growth potential.

What This Means for Investors Based on the current GF Value™ of $57.48, Microchip Technology Inc appears to be significantly overvalued at its current price of $91.52. Investors should carefully consider the risks associated with such a high valuation, especially in light of the recent insider selling and the low valuation rank in the GF Score™. It may be prudent to monitor the stock for signs of correction or improved valuation metrics before making investment decisions.

For the complete analysis, visit the Microchip Technology Inc MCHP stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is MCHP's GF Score™?

MCHP's GF Score™ is 76/100, indicating an above-average rating based on key metrics such as financial strength, profitability, growth, valuation, and momentum.

Is MCHP overvalued or undervalued?

MCHP is currently overvalued, with a GF Value™ estimate of $57.48 compared to its market price of $91.52, suggesting it is 59.2% overvalued.

What is MCHP's P/E ratio?

MCHP's current P/E ratio is 435.8x, which is significantly higher than its 5-year median P/E of 27.2x, indicating a high valuation compared to its historical performance.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

On June 02, 2026, Microchip Technology Inc MCHP shares rose 5.9% to a current price of $96.96. Over the past year, the stock has shown significant growth, with a 66.0% increase, while its 52-week range has been between $48.52 and $105.91.

GF Value™ verdict: Current price is $96.96 vs GF Value™ of $57.57, indicating a 68.4% overvaluation.GF Score™: 76/100, which is classified as Above Average.Most notable signal: Insiders sold $51.2 million worth of shares in the last 3 months, with no buying activity reported. Is MCHP Overvalued or Undervalued? Currently, Microchip Technology Inc's stock is trading at $96.96, which is significantly above its GF Value™ of $57.57. This indicates that the stock is overvalued by approximately 68.4%. The GF Valuation label identifies the stock as "Significantly Overvalued," suggesting that the market price does not accurately reflect the company's intrinsic value. The substantial difference between the current price and the GF Value™ serves as a warning signal for potential risks associated with investing at this price level.

GF Value™ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. Given that MCHP is trading at a premium, the margin of safety is minimal, and investors might face downside risk if the stock price adjusts to align more closely with its intrinsic value.

How Does MCHP's Valuation Compare to Its History? Metric Current Historical P/E (TTM) 461.7x 27.2x Forward P/E 30.9x N/A The current P/E ratio of 461.7x is dramatically above its 5-year median P/E of 27.2x, indicating that the stock is currently trading at an exorbitantly high valuation compared to its historical averages. This alignment with the GF Value™ verdict suggests that MCHP is overvalued, as the P/E analysis corroborates the notion that the stock price is not just above its intrinsic value, but at an extraordinary premium compared to its own historical performance.

What Does MCHP's GF Score™ Tell Us? Metric Rating GF Score™ 76 Financial Strength 5/10 Profitability 6/10 Growth 7/10 Valuation 3/10 Momentum 10/10 The GF Score™ of 76/100 reflects an Above Average rating, indicating that MCHP has strengths in growth (7/10) and momentum (10/10), suggesting robust operational performance and positive market movements. However, the Valuation rating of 3/10 indicates that the stock is not favorably priced relative to its intrinsic value, which aligns with the previously discussed overvaluation concerns. The financial strength score of 5/10 suggests that while the company is stable, it does not demonstrate exceptional resilience compared to its peers.

What Are Insiders Doing with MCHP Stock? Recent insider activity has shown a significant trend, with insiders selling a total of $51.2 million in shares over the past three months, with no buying activity reported during this period. This pattern may suggest a lack of confidence from insiders regarding the stock's future performance at its current valuation. Such selling activity can often be a red flag for potential investors, indicating that those closest to the company might believe that the stock is overvalued or that future growth prospects may not meet current market expectations.

What This Means for Investors Based on the analysis of MCHP's current market price in relation to its GF Value™, the stock is considered overvalued at this time. While the company shows decent growth and momentum, the significant premium over intrinsic value poses potential risks for investors looking to enter at this price point.

For the complete analysis, visit the Microchip Technology Inc MCHP stock page. You can also explore the GF Value™ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.

Frequently Asked Questions What is MCHP's GF Score™?

The GF Score™ for Microchip Technology Inc is 76/100, indicating that it is rated Above Average based on key performance metrics.

Is MCHP overvalued or undervalued?

MCHP is considered overvalued with a GF Value™ of $57.57 compared to its current market price of $96.96, indicating a significant premium.

What is MCHP's P/E ratio?

The current P/E (TTM) ratio for MCHP is 461.7x, which is substantially higher than its 5-year median P/E of 27.2x, supporting the conclusion that the stock is overvalued.

This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Microchip Technology Incorporated (MCHP) Presents at 2026 Evercore Global TMT Conference Transcript

License supports the company’s growing footprint in Armenia as the region emerges as a hub for advanced semiconductor development June 04, 2026 07:18 ET  | Source: Microchip Technology Inc.

YEREVAN, Armenia, June 04, 2026 (GLOBE NEWSWIRE) -- Microchip Technology’s (Nasdaq: MCHP) Armenian office has received approval from the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) for an export license authorizing the use of advanced technology under Export Control Classification Number (ECCN) 3E001 and related high‑performance hardware under ECCN 3A001.a.7.b. Such authorization requires companies to demonstrate rigorous compliance with U.S. export regulations, including clear definition of permitted end uses, controlled access to sensitive technology and robust internal compliance safeguards. The license enables Microchip to securely and responsibly develop advanced semiconductor technologies in Armenia within the global regulatory framework.

“As the only multinational semiconductor company in Armenia to receive a site license from BIS, this approval highlights our commitment to high‑value semiconductor innovation through strong global operations and solidifies our support of the region’s rapidly growing technology ecosystem,” said Shakeel Peera, vice president of Microchip’s FPGA business unit. “The license enables our Armenia engineering team to participate in the development of advanced FPGA technologies while meeting the rigorous compliance standards required for controlled engineering work.”

The designation related to ECCN 3E001 applies to certain controlled technology associated with advanced electronic and FPGA development. In practical terms, the authorization allows approved Armenia-based personnel to access and work with specified controlled technology for authorized research and development programs, subject to U.S. export-control regulations, Microchip’s internal compliance processes, technology-control procedures, training requirements and access restrictions.

“This represents a crucial precedent and a significant step toward strengthening Armenia’s position within the global semiconductor supply chain. The approval of the export license reduces barriers, supporting broader participation for Armenia’s engineering talent in advanced chip design, full-complexity development and validation processes. It opens new opportunities for innovation and collaboration with partners such as Microchip Armenia,” said Mkhitar Hayrapetyan, Minister of High-Tech Industry of the Republic of Armenia. “This achievement is a tangible outcome of the Memorandum of Understanding on Artificial Intelligence and Semiconductors signed between Armenia and the United States on August 8, 2025, subsequent agreements with high-level government officials, ongoing coordination of the Ministry of High-Tech Industry and the Ministry of Foreign Affairs of the Republic of Armenia and an effective public-private partnership. It further reinforces Armenia’s role as an emerging hub for high-tech development.”

Microchip’s FPGA portfolio includes the PolarFire® family of low-power, high-performance FPGAs and SoCs, along with other programmable logic solutions designed for industrial, communications, automotive, AI/ML, aerospace and defense and embedded computing applications. The Armenia office’s expanded ability to support FPGA technology development reinforces Microchip’s commitment to global engineering collaboration and investment in innovative semiconductor development.

The company’s presence in Armenia was established through the acquisition of Instigate Semiconductor, a subsidiary of Instigate Holding, in 2023. Since then, its local workforce has expanded by 43 percent with offices in four key locations across the country—Yerevan, Gyumri, Vanadzor and Ijevan—and a focus on hardware and software development, application engineering and customer support under Microchip’s FPGA business unit. For more information, visit the Microchip Armenia webpage.

Resources
High-res images available through Flickr or editorial contact (feel free to publish):
·Application image: https://www.flickr.com/gp/microchiptechnology/GJ5H026HzE

About Microchip Technology:
Microchip Technology Inc. is a broadline supplier of semiconductors committed to making innovative design easier through total system solutions that address critical challenges at the intersection of emerging technologies and durable end markets. Its easy-to-use development tools and comprehensive product portfolio supports customers throughout the design process, from concept to completion. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support and delivers solutions across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. For more information, visit the Microchip website at www.microchip.com.

Note: The Microchip name and logo, the Microchip logo and PolarFire are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

CHANDLER, Ariz., June 09, 2026 (GLOBE NEWSWIRE) -- Microchip Technology (Nasdaq: MCHP) today announces the release of the TimePictra® 12 platform, a major software upgrade to its synchronization management software designed to help critical infrastructure operators manage advanced timing architectures with greater visibility, automation and control. The new version delivers a redesigned graphical user interface (GUI), expanded automation capabilities and enhanced support for the latest high‑accuracy timing technologies.

As telecom, power, transportation, data center and other critical infrastructure networks evolve, operators are increasingly deploying more sophisticated synchronization architectures to improve resilience, reduce dependence on GNSS and maintain precise clock alignment across distributed environments. The TimePictra 12 platform addresses these requirements with enhanced capabilities for managing High-Accuracy Time Transfer (HA-TT) connections, monitoring GNSS observables using Microchip’s BlueSky™ technology and maintaining clock alignment using SkyWire™ technology.

The platform is also designed to strengthen GNSS visibility and resiliency by monitoring using BlueSky technology. By enabling centralized monitoring of GNSS-observables, the TimePictra 12 platform helps operators better understand GNSS conditions, identify anomalies and manage timing infrastructure in environments where GNSS availability, integrity and security are critical.

In addition, the TimePictra 12 platform supports the maintenance of clock alignment using SkyWire technology, helping operators preserve synchronization accuracy across distributed network elements. This capability is especially important as networks become more distributed, automated and dependent on precise phase and frequency alignment.

“Operators are looking for more than basic synchronization monitoring, they need tools that help them manage advanced timing architectures with confidence,” said Randy Brudzinski, corporate vice president of Microchip’s frequency and time systems business. “With the TimePictra 12 platform, Microchip is enabling customers to manage HA-TT connections, GNSS reception and dispersed clock alignment from a centralized platform designed for the next generation of critical infrastructure networks.”

The TimePictra 12 software suite introduces a refreshed user experience designed to simplify how operators interact with large, meshed synchronization environments. The modernized GUI makes it easier to view network relationships, identify issues and streamline ongoing management, helping reduce operational overhead for telecom, power, data center and other timing‑dependent sectors such as telecom, power, transportation, data centers and AI infrastructure.

To help minimize deployment challenges, the software is designed to accelerate network rollouts, upgrades and configuration activities. The TimePictra 12 platform supports up to 5,000 elements, more than double the network size of earlier versions, providing increased capacity for large-scale synchronization deployments.

The TimePictra 12 platform supports a broad range of Microchip’s synchronization products, including the TimeProvider® 4100, 4500 and 5000 grandmaster clocks, SSU-2000, TimeCesium® 4400 and 5071 products, Skywire technology and BlueSky GNSS Firewall. It enables centralized monitoring, configuration and management of these devices across critical infrastructure networks such as 5G, utilities, transportation, power substations, AI and datacenters.

Device compatibility may depend on software versions and licensing, so customers should consult official Microchip documentation for the latest supported products and configuration details. For more information about Microchip’s timing and synchronization solutions, visit the website.

Pricing and Availability

The TimePictra 12 platform is now available for purchase or as an upgrade. For additional information and to purchase, contact a Microchip sales representative or authorized worldwide distributor.

Resources

High-res images available through Flickr or editorial contact (feel free to publish):

Application image: www.flickr.com/photos/microchiptechnology/55210983607/sizes/l About Microchip Technology:

Microchip Technology Inc. is a broadline supplier of semiconductors committed to making innovative design easier through total system solutions that address critical challenges at the intersection of emerging technologies and durable end markets. Its easy-to-use development tools and comprehensive product portfolio supports customers throughout the design process, from concept to completion. Headquartered in Chandler, Arizona, Microchip offers outstanding technical support and delivers solutions across the industrial, automotive, consumer, aerospace and defense, communications and computing markets. For more information, visit the Microchip website at www.microchip.com.

Note: The Microchip name and logo and the Microchip logo are registered trademarks of Microchip Technology Incorporated in the U.S.A. and other countries. TimePictra, TimeCesium and TimeProvider are registered trademarks of Microchip Technology Inc. in the U.S.A. BlueSky and SkyWire are trademarks of Microchip Technology Inc. in the U.S.A. and other countries. All other trademarks mentioned herein are the property of their respective companies.

Editorial Contact:
Kim Dutton
480-792-4386
[email protected]   

Here’s the most important thing to understand about this morning's inflation report: the scary number is the one the Federal Reserve is specifically built to ignore.

Headline CPI rose 4.2% year over year in May, the hottest reading in three years, driven by the energy-supply shock from the Iran war. That will dominate the headlines and send the nervous crowd scrambling into energy and defensive "inflation hedges."

Central banks fight demand-driven inflation. They do not, and cannot, fight supply shocks. A war-driven spike in crude oil is the single clearest example of a supply shock there is, and the Fed's entire playbook for one is to look straight through it — because raising rates does nothing to unclog the Strait of Hormuz, and tightening into a supply-driven price spike only deepens the economic damage.

The Fed knows this. The market, fixated on the 4.2% print, is in the process of forgetting it.

Digging Deeper into May’s CPI PrintAnd when you actually look at what the Fed cares about, the picture inverts completely. Core CPI rose just 0.2% on the month, below the 0.3% consensus. Strip out food, shelter, and energy — the cleanest read on underlying, demand-driven pricing — and inflation is running at roughly 2.4% year over year.

That is essentially at target. The honest interpretation of today's report is not "inflation is back"; it's "the economy's underlying inflation is cooling while a geopolitical oil spike temporarily distorts the headline."

That distinction is the whole ballgame, because a cooling core keeps the path to rate cuts wide open — and rate cuts are the lifeblood of the aggressive, rate-sensitive corners of the market that the defensive crowd has been busy abandoning.

This is the repositioning that matters. While the obvious trade chases oil, the more sophisticated money reads the core, concludes the Fed's easing path comes back into play, and rotates back toward risk. The footprints are already visible: even through the inflation scare this year, a handful of AI names have driven roughly half of the S&P 500's return this year.

Technology has quietly been among the best-performing sectors, and the largest allocators remain most convicted on AI while the rally broadens beyond the megacaps. A Fed that's free to cut pours fuel on exactly that fire. Here are two Zacks Rank #1 (Strong Buy) names built for it — both AI-levered, both mid-cycle, both precisely the kind of stock that outperforms when discount rates fall and risk appetite returns.

Stocks to WatchThe first is Microchip Technology (MCHP - Free Report) , and it's the quintessential expression of the trade. Microchip is a microcontroller and analog chipmaker emerging from a brutal inventory-correction cycle.

The turn is now showing up in the numbers. Management guided June-quarter revenue to a midpoint of $1.45 billion, up 35% from a year ago and 11% sequentially, citing inventory correcting rapidly toward its long-term model.

The estimate revisions — the engine of the Zacks Rank — are exploding higher. The current-quarter consensus calls for EPS growth of 144.4% year over year, the Zacks Consensus Estimate has jumped 17.86% over just the last 60 days on five upward revisions and zero cuts, and MCHP carries a Zacks Rank #1 (Strong Buy). A cyclical chipmaker inflecting upward, with rising AI-edge and aerospace exposure, is a high-beta way to play both the semiconductor recovery and a potentially friendlier Fed.

Image Source: Zacks Investment Research

The second is Flex (FLEX - Free Report) , the contract-manufacturing giant that has reinvented itself as a core arms dealer of the AI data center buildout.

Its latest quarter was excellent. Fiscal fourth-quarter adjusted EPS of $0.93 beat the Zacks Consensus Estimate by 8.1% and rose from $0.73 a year earlier, on revenue of $7.5 billion (up 17%), with the Cloud and Power Infrastructure segment the standout.

Flex now carries a Zacks Rank #1 (Strong Buy). It has beaten estimates in each of the last four quarters, with an average surprise of 9.5%. At COMPUTEX 2026, Flex unveiled a 110 kW power shelf for NVIDIA's Vera Rubin NVL72 platform, underscoring its "grid-to-chip" position in AI power. That spin-off is a potential value-unlock catalyst on top of the underlying momentum.

Image Source: StockCharts

Bottom LineThe defensive, buy-energy reaction takes today's headline at face value — and the headline is the head-fake.

The signal is underneath it: a cooling core that hands the Fed room to ease, and a market quietly repositioning toward the aggressive growth and cyclical-recovery names that thrive when it does. Microchip and Flex are two Zacks Rank #1 ways to be early to that move while the crowd is still staring at the wrong number.

Key Takeaways Microchip rolled out TimePictra 12 to manage complex synchronization for critical infrastructure. TimePictra 12 adds BlueSky GNSS observables monitoring and SkyWire clock alignment support. Platform boosts deployments with redesigned GUI, automation, and support for up to 5,000 elements. Microchip Technology (MCHP - Free Report) has introduced the TimePictra 12 platform, a significant upgrade to its synchronization management software aimed at helping critical infrastructure operators manage increasingly complex timing architectures with improved visibility, automation and operational control. The latest version features a redesigned graphical user interface (GUI), enhanced automation capabilities and broader support for advanced high-accuracy timing technologies.

As networks across telecommunications, power, transportation, data centers and other critical infrastructure sectors continue to evolve, operators are deploying more sophisticated synchronization architectures to improve resilience, reduce reliance on Global Navigation Satellite Systems (“GNSS”) and maintain accurate clock synchronization across distributed environments.

TimePictra 12 addresses these needs through advanced capabilities for managing High-Accuracy Time Transfer (HA-TT) connections, monitoring GNSS observables using Microchip’s BlueSky technology and maintaining clock synchronization through SkyWire technology.

The platform enhances GNSS visibility and resilience by enabling centralized monitoring of GNSS observables through BlueSky technology. This capability allows operators to gain deeper insights into GNSS conditions, detect anomalies and effectively manage timing infrastructure in environments where its availability, integrity and security are critical.

TimePictra 12 also supports clock alignment maintenance through SkyWire technology, helping organizations preserve synchronization accuracy across distributed network elements. This functionality is becoming increasingly important as networks grow more decentralized, automated and dependent on precise phase and frequency synchronization.

According to Microchip’s frequency and time systems business leadership, the growing complexity of modern timing architectures requires solutions that go beyond basic synchronization monitoring. The TimePictra 12 platform has been developed to enable centralized management of HA-TT connections, GNSS reception and distributed clock alignment, supporting the next generation of critical infrastructure networks.

The software suite delivers a modernized user experience designed to simplify the management of large and interconnected synchronization environments. The updated GUI improves network visualization, facilitates issue identification and streamlines routine management tasks, helping reduce operational complexity across sectors such as telecommunications, power, transportation, data centers and AI infrastructure.

To simplify deployment and expansion activities, the platform is designed to accelerate network rollouts, upgrades and configuration processes. It can support up to 5,000 network elements, more than doubling the capacity of previous versions and enabling larger-scale synchronization deployments.

TimePictra 12 supports a wide range of Microchip synchronization solutions, including the TimeProvider 4100, 4500 and 5000 grandmaster clocks, SSU-2000, TimeCesium 4400 and 5071 products, SkyWire technology and the BlueSky GNSS Firewall. The platform provides centralized monitoring, configuration and management capabilities for critical infrastructure applications, including 5G networks, utilities, transportation systems, power substations, AI infrastructure and data centers.

The launch of TimePictra 12 is expected to strengthen Microchip’s position in the timing and synchronization market by expanding the capabilities of its software ecosystem and enhancing the value of its hardware portfolio. By supporting larger deployments, advanced timing technologies and centralized network management, the platform can drive greater adoption of Microchip’s synchronization products, deepen customer engagement and create additional opportunities across rapidly growing sectors such as 5G, AI infrastructure, utilities and data centers.

Taking a Look at Launches by Other Tech CompaniesIn 2025, SiTime Corporation (SITM - Free Report) , a provider of precision timing solutions, announced the launch of its TimeFabric software suite. When combined with SiTime’s oscillators and clocks, the software delivers up to nine times greater time-synchronization accuracy than conventional quartz-based solutions, helping improve system performance and resource utilization in AI data centers.

The TimeFabric software suite, launched by SiTime, comprises two key modules: synchronization software that complies with IEEE 1588 standards and proprietary technology that extends critical holdover performance to up to 24 hours. Together, these capabilities support highly accurate and resilient timing across advanced computing and networking environments.

In 2024, Adtran (ADTN - Free Report) launched its Oscilloquartz Time Scale System, developed to meet the precise timekeeping requirements of national metrology institutes, scientific research facilities and other applications demanding the highest levels of accuracy and traceability. Adtran’s Oscilloquartz Time Scale System delivers exceptional timekeeping by integrating up to eight different clock types, including optical cesium atomic clocks, hydrogen maser clocks and GNSS receivers, into a single, stable time scale. Similar to Microchip’s TimePictra 12 platform, Adtran’s launch focuses on helping operators manage increasingly complex synchronization environments while improving resilience and timing accuracy.

MCHP’s Price Performance, Valuation & EstimatesShares of MCHP have gained in double digits (% wise) over the past six months, but lagged the Zacks Semiconductor-Analog-and-Mixed industry’s return.

6-Month Price ComparisonImage Source: Zacks Investment Research

In terms of forward 12-month Price/Sales (P/S), Microchip is trading at a discount compared with its industry.

Image Source: Zacks Investment Research

See how the Zacks Consensus Estimate for MCHP’s earnings has been revised over the past 90 days.

Image Source: Zacks Investment Research

MCHP’s Zacks Rank

MCHP currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.  

Key Takeaways Microchip's Nantes facility expanded its QML MIL-PRF-38535 certification to include Class Y.Class Y adds support for advanced packaging, including non-hermetic semiconductor solutions.Nantes can qualify and test PIC64-HPSC chips for spaceflight computing and mission assurance. Microchip Technology (MCHP - Free Report) announced that the Nantes facility in France has expanded the scope of its Qualified Manufacturers List (“QML”) MIL-PRF-38535 certification to include QML Class Y. This underscores the company’s commitment to providing high-reliability semiconductor solutions for aerospace and defense applications. The facility, which previously held QML Classes V and Q certifications, has now added Class Y to its certification portfolio.

Since 1999, the Nantes site has maintained QML certifications for Classes Q and V, supporting stringent space and defense mission requirements. The addition of Class Y certification extends the facility’s capabilities to include advanced packaging technologies, such as non-hermetic solutions. This enhancement enables greater integration levels and supports the sophisticated semiconductor architectures required for next-generation military and space programs.

The Class Y certification further strengthens the Nantes facility’s role within Microchip’s European manufacturing network for high-reliability devices. In addition to this certification, the site holds ESCC QML and AS9100:2018 certifications, making it one of the company’s most highly qualified manufacturing locations for aerospace and defense solutions.

The Nantes facility is also equipped to support the qualification and testing of Microchip’s PIC64 High-Performance Spaceflight Computing (PIC64-HPSC) family, a series of radiation-hardened and radiation-tolerant 64-bit microprocessors designed for space exploration. This capability enhances the company’s ability to address evolving customer requirements related to electrical testing, qualification and long-term mission assurance in demanding operating environments.

The certification upgrade at Microchip’s Nantes facility is expected to strengthen the company’s position in the aerospace and defense market by broadening its portfolio of qualified high-reliability semiconductor solutions. With the addition of QML Class Y certification, the facility can support advanced packaging technologies, including non-hermetic devices, enabling higher integration levels and more sophisticated chip designs. This expanded capability will help Microchip address the evolving requirements of next-generation military and space programs, enhance its manufacturing flexibility in Europe, and create additional opportunities in high-growth, mission-critical applications.

Microchip maintains qualification facilities in both the United States and Europe, each certified to specific military standards and classes aligned with their respective product focus areas. In the United States, the company’s San Jose, CA, facility is qualified to MIL-PRF-38535 Classes Q, V and Y for advanced digital and space applications, while its Garden Grove, CA, facility supports Class Q certification for analog and mixed-signal devices.

In April this year, Microchip announced that it received IEC 62443-4-1 Maturity Level 2 certification from UL Solutions (ULS - Free Report) , validating that the product development process adheres to globally recognized secure-by-design principles. The certification provides independent assurance that the company follows a mature and repeatable cybersecurity framework.UL Solutions’ certification verifies that Microchip embeds cybersecurity measures throughout the entire hardware and software development lifecycle—from the initial design stage to product end-of-life—and consistently implements these security practices across its business units as well as its global design and manufacturing facilities. UL Solutions is a provider of safety, software and advisory services worldwide

Taking a Look at Another Certification WinsAccording to an EE Times Asia report, Teledyne e2v, a subsidiary of Teledyne Technologies (TDY - Free Report) , expanded its portfolio of QML Class Y-qualified products, including the EV12AQ600 space-qualified analog-to-digital converter. The certification framework enabled Teledyne to incorporate advanced packaging and manufacturing technologies that were not fully supported under traditional QML Class V requirements. This helped Teledyne e2v address next-generation space-system requirements while ensuring reliability for long-duration missions.

MCHP’s Price Performance, Valuation & EstimatesShares of MCHP have gained in double digits (% wise) so far this year, but lagged the Zacks Semiconductor-Analog-and-Mixed industry’s return.

YTD Price ComparisonImage Source: Zacks Investment Research

In terms of forward 12-month Price/Sales (P/S), Microchip is trading at a discount compared with its industry.

Image Source: Zacks Investment Research

See how the Zacks Consensus Estimate for MCHP’s earnings has been revised over the past 90 days.

Image Source: Zacks Investment Research

MCHP’s Zacks RankMCHP currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

PPL (PPL - Free Report) reported $2.77 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 10.8%. EPS of $0.63 for the same period compares to $0.60 a year ago.

The reported revenue represents a surprise of +5.86% over the Zacks Consensus Estimate of $2.62 billion. With the consensus EPS estimate being $0.61, the EPS surprise was +4.13%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how PPL performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Rhode Island Regulated: $595 million versus $658.5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5% change.Revenues- Pennsylvania Regulated: $971 million versus the two-analyst average estimate of $867.71 million. The reported number represents a year-over-year change of +18.6%.Operating Income- PPL Electric Utility: $294 million compared to the $324.58 million average estimate based on two analysts.View all Key Company Metrics for PPL here>>>

Shares of PPL have returned -7.6% over the past month versus the Zacks S&P 500 composite's +11% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

PPL Corporation (PPL) maintains a Hold rating as shares trade near intrinsic value and historical valuation metrics. Q1 results were solid, with EPS and revenue beats, and management reaffirmed 6%-8% annual EPS growth through 2029. Data center-driven load growth and regulatory progress support PPL's $23 billion capex plan, but risks include rate-case outcomes and financing costs.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Let's take a look at what these Wall Street heavyweights have to say about PPL (PPL - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

PPL currently has an average brokerage recommendation (ABR) of 1.53, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 16 brokerage firms. An ABR of 1.53 approximates between Strong Buy and Buy.

Of the 16 recommendations that derive the current ABR, 11 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 68.8% and 6.3% of all recommendations.

Brokerage Recommendation Trends for PPL

Check price target & stock forecast for PPL here>>>

While the ABR calls for buying PPL, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Should You Invest in PPL?Looking at the earnings estimate revisions for PPL, the Zacks Consensus Estimate for the current year has declined 0.3% over the past month to $1.95.

Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for PPL. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, it could be wise to take the Buy-equivalent ABR for PPL with a grain of salt.

Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact , /PRNewswire/ -- PPL Corporation (NYSE: PPL) declared a quarterly common stock dividend on Wednesday, May 13, 2026 of $0.2850 per share, payable Jul. 1, 2026 to shareowners of record as of Jun. 10, 2026.

About PPL
PPL Corporation (NYSE: PPL), headquartered in Allentown, Pennsylvania, is a leading U.S. energy company focused on providing electricity and natural gas safely, reliably and affordably to more than 3.6 million customers in the U.S. PPL's high-performing, award-winning utilities are addressing energy challenges head-on by building smarter, more resilient and more dynamic power grids and advancing sustainable energy solutions. For more information, visit www.pplweb.com

Note to Editors: Visit our media website at www.pplnewsroom.com for additional news about PPL Corporation. 

Contacts:

For news media: Ryan Hill, 610-774-4033

For financial analysts: Andy Ludwig, 610-774-3389

SOURCE PPL Services Corporation

Also from this source

PPL NYSE: PPL reported higher first-quarter earnings and reaffirmed its 2026 and long-term financial targets, while executives highlighted regulatory developments, data center-driven load growth and potential generation investments across the company’s service territories.

President and CEO Vince Sorgi said PPL delivered “strong financial and operational results” in the first quarter, reporting GAAP earnings of $0.60 per share. Adjusting for special items, ongoing earnings were $0.63 per share. PPL reaffirmed its 2026 ongoing earnings guidance of $1.90 to $1.98 per share, with a midpoint of $1.94.

The company also remains on track to complete about $5.1 billion of planned investments in 2026. Longer term, PPL continues to project approximately $23 billion of capital investment through 2029, supporting average annual rate base growth of 10.3%. That forecast excludes any investments that could come from the company’s joint venture with Blackstone.

Get PPL alerts:

Sorgi said PPL is maintaining its long-term financial targets, including 6% to 8% annual earnings-per-share growth through at least 2029, with compound annual growth expected near the top end of that range. The company also continues to target 4% to 6% annual dividend growth.

Quarterly Earnings Improve on Kentucky Rates, Transmission Revenue Chief Financial Officer Joe Bergstein said first-quarter GAAP earnings rose to $0.60 per share from $0.56 per share in the prior-year quarter. Special items totaled $0.03 per share, primarily tied to an ISO New England transmission return-on-equity reduction and customer and meter system integration impacts, partially offset by regulatory asset treatment of costs related to PPL’s IT transformation in Kentucky.

Ongoing earnings increased by $0.03 per share from the first quarter of 2025. Bergstein said the improvement was driven mainly by higher base rate recovery in Kentucky and higher transmission revenues from additional capital investments, partly offset by higher depreciation and financing costs.

Kentucky segment results increased by $0.03 per share, mainly due to new retail rates that took effect Jan. 1. Pennsylvania regulated results reflected higher transmission revenue from additional capital investments, offset by higher operating, depreciation and interest expenses. Rhode Island results benefited from higher rider revenue returns, including recovery through the infrastructure, safety and reliability mechanism and FERC formula rates, but were offset by higher depreciation expense.

Bergstein also noted that PPL completed a $1.15 billion equity units offering in February, with a purchase contract for PPL common shares settling in February 2029. He said the transaction has de-risked about two-thirds of the total equity needed to support the company’s current capital expenditure plan.

Pennsylvania Rate Settlement Advances Sorgi said PPL Electric Utilities reached a settlement with the majority of interveners in its Pennsylvania distribution base rate case. The case was filed in the third quarter of last year after more than 10 years since the utility’s prior base rate case filing.

According to Sorgi, the settlement would result in bill increases of less than 4% across all customer classes, while keeping PPL Electric’s delivery rates among the lowest in Pennsylvania. The company also agreed to a two-year stay-out period after new base rates are implemented.

The settlement includes measures aimed at vulnerable customers, including increased hardship fund bill credits, improved access to assistance programs, elimination of reconnection fees, streamlined return of security deposits and a higher annual low-income weatherization budget.

PPL also created a proposed large load customer rate class and electric service tariff, which Sorgi said includes protections for other customers, including a 10-year load requirement and financial commitments. He said the proposed tariff and rate class would provide about $11 million annually to support residential low-income programs.

Administrative law judges recommended approval of the settlement without modification on April 17. PPL expects a final decision from the Pennsylvania Public Utility Commission by the end of June, with new rates effective July 1.

Data Center Demand Continues to Grow PPL executives said data center development continues to expand in Pennsylvania. Sorgi said projects in advanced stages of planning now total 28.3 gigawatts, up 12% from 25.2 gigawatts discussed during the company’s year-end update call. These projects have executed letters of agreement or electric service agreements with financial commitments from developers.

Of that total, about 10 gigawatts now have signed electric service agreements, including contracts with QTS, AWS, PowerHouse, CoreWeave and others, Sorgi said. About 5 gigawatts of advanced-stage projects are already under construction.

In response to an analyst question, Sorgi said PPL’s current plan includes about $1.3 billion of incremental transmission capital expenditures. He said the 28-gigawatt pipeline could represent “at least another half a billion” of upside beyond the current plan, though some of that spending would likely occur beyond 2029.

Sorgi said PPL’s electric service agreements include prepayments, credit support and minimum load obligations designed to ensure developers, rather than existing customers, bear financial risk if projects do not proceed as planned.

Kentucky is also seeing increased load growth. Sorgi said LG&E and KU’s development pipeline now reflects 12.9 gigawatts of potential new load through 2032, up nearly 4 gigawatts from the year-end update. Nearly 12 gigawatts of active requests are tied to data center demand, with roughly one-third considered highly active. About 650 megawatts are under construction or agreement.

Based on updated planning assumptions, PPL now projects approximately 3.5 gigawatts of expected new load by 2032, compared with about 1.8 gigawatts assumed in its most recent Kentucky Certificate of Public Convenience and Necessity forecast.

Blackstone Joint Venture and Generation Options Sorgi said momentum is building around PPL’s joint venture with Blackstone Infrastructure, which is focused on generation solutions tied to data center growth in Pennsylvania. He said interest from hyperscalers and developers remains high, and the joint venture is doing upfront development work so it can move quickly once commercial agreements are finalized.

The joint venture is engaged in discussions with gas pipeline companies to ensure access to low-cost Marcellus Shale gas for future generation projects. Sorgi said PPL is executing multiple gas turbine reservation agreements and has submitted requests for multiple generation projects into PJM’s interconnection queue for land sites currently under the company’s control.

However, Sorgi emphasized that PPL will not build projects without signed energy supply services agreements. He said the company expects any commercial structures to support a “utility-like risk profile” through long-term contracts.

During the question-and-answer session, Sorgi said it is “probably likely” that PPL would have something meaningful to announce this year regarding such agreements, though he cautioned that the contracts are complex and require review by hyperscaler customers.

In Kentucky, PPL announced partnerships with Rye Development and X-energy. The Rye partnership will evaluate a 266-megawatt pumped storage hydro project in Bell County, converting former coal mine land into an energy storage facility with up to eight hours of storage. Sorgi said the project’s commercial operation date is currently projected for 2031, with initial cost estimates of about $1.3 billion, excluding potential eligibility for a 50% investment tax credit. The project is not in PPL’s current capital plan or earnings projections.

PPL’s collaboration with X-energy will explore deployment of X-energy’s Xe-100 small modular reactor in Kentucky to support large load customers, including data centers, with long-term carbon-free electricity. Sorgi said any nuclear development would proceed through a disciplined, phased approach and would be gated by economics, regulatory certainty and capital discipline.

Rhode Island Investments and Affordability Measures In Rhode Island, Sorgi said Rhode Island Energy received approval for more than $330 million of infrastructure investments through its latest annual electric and gas infrastructure, safety and reliability plans. Recovery began April 1.

The company’s Rhode Island base rate case remains on track, with evidentiary hearings planned for June and July and new rates expected to take effect Sept. 1. Rhode Island Energy is requesting a revenue requirement increase over two years, consisting of $181 million in year one and an additional $49 million in year two.

Sorgi said Rhode Island Energy also filed a new hold harmless commitment proposal expected to provide bill credits that would significantly offset the impact of the proposed base rate increase. The credits are expected to begin in the first quarter of 2027.

Throughout the call, executives emphasized affordability as a central focus. Sorgi said PPL does not view growth and affordability as competing objectives, adding that incremental load, disciplined investment and generation development can improve system utilization and help lower overall customer costs if executed properly.

About PPL NYSE: PPLPPL Corporation is an energy company that owns and operates electric transmission and distribution infrastructure and provides related customer services. The company's core business centers on delivering electricity to residential, commercial and industrial customers through regulated utility operations, maintaining grid reliability, responding to outages and managing customer billing and account services.

PPL's activities include construction and maintenance of distribution and transmission lines, meter and grid management, and programs to support energy efficiency and the interconnection of distributed resources.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in PPL Right Now?Before you consider PPL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PPL wasn't on the list.

While PPL currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Key Takeaways PPL raised its quarterly dividend 4.6% to 28.5 cents a share, or $1.14 annualized. PPL targets 4-6% dividend growth through 2029 and expects a 50-60% payout ratio.PPL plans $23B in investments, with over 60% eligible for contemporaneous recovery to support cash flows. PPL Corporation (PPL - Free Report) continues to increase its shareholders’ value by paying dividends at regular intervals and raising the dividend rate annually. The company has a long history of rewarding shareholders, courtesy of its strong operational performance and resilient cash-flow generation.

The company’s board of directors has approved a 4.6% year-over-year increase in quarterly dividend to 28.5 cents per share from 27.25 cents, resulting in an annualized dividend of $1.14. PPL has distributed dividends for 80 consecutive years, targets annual dividend growth of 4-6% through 2029 and expects a 50-60% payout ratio.

While current dividend payments do not guarantee future payouts at the same rate, a company’s financial performance and long-term plans can help assess its ability to sustain shareholder-friendly initiatives going forward.

PPL's regulated structure, along with its focus on generation, transmission and distribution projects, supports its future growth and steady cash-flow generation. The company benefits from robust economic development in its service territory and increasing clean electricity demand from data centers. This supports stable revenue growth and strengthens the company’s overall financial performance.

In Pennsylvania, advanced-stage data center demand has increased to nearly 28.3 gigawatt (GW) from 25.2 GW, while Kentucky’s economic development pipeline now indicates potential load growth of 12.9 GW through 2032, up from the earlier estimate of 8.5 GW. The company targets 6-8% annual earnings growth through 2029, supported by $23 billion in capital investments and 10.3% rate base growth. More than 60% of PPL’s capital investment plan qualifies for “contemporaneous recovery,” which mitigates the effects of regulatory lag on earnings and ensures regular cash flows.

Utilities' Long History of Dividend PaymentUtility companies benefit from stable cash flows generated by regulated operations and essential services, supporting consistent dividend payments across economic cycles. Expanding rate bases, infrastructure investments and predictable earnings growth further strengthen their ability to deliver reliable long-term returns for income-focused investors.

Duke Energy (DUK - Free Report) has rewarded its shareholders through consistent dividend payments for the past 100 years. The company’s board has approved a quarterly dividend of $1.065 per share, resulting in an annualized dividend of $4.26.

Consolidated Edison, Inc. (ED - Free Report) has consistently enhanced shareholder value through regular dividend payments and has increased its annual dividend for 52 consecutive years. The company’s board has approved a quarterly dividend of 88.75 cents, resulting in an annualized dividend of $3.55 per share.

PPL’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 EPS indicates an increase of 7.73% and 8.21%, respectively, year over year.

Image Source: Zacks Investment Research

PPL's Stock Trading at a PremiumPPL is trading at a premium relative to the industry, with a forward 12-month price-to-earnings of 18.0X compared with the industry average of 15.86X.

Image Source: Zacks Investment Research

PPL’s Stock Price PerformanceIn the past three months, the company’s shares have plunged 2.8% compared with the industry’s 4.9% decline.

Image Source: Zacks Investment Research

PPL’s Zacks RankPPL currently has a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Key Takeaways PPL is tapping AI data-center expansion to lift clean electricity demand in Pennsylvania and Kentucky. PPL's Pennsylvania pipeline hit 28.3 GW; about 10 GW is under ESAs and 5 GW is already being built. PPL plans $23B in regulated capex (2026-2029) to connect new loads and boost reliability, cutting outages. PPL Corporation (PPL - Free Report) is benefiting from a rise in clean electricity demand from the expansion of AI-based data centers across its Pennsylvania and Kentucky service territories. AI-driven data centers require substantially higher power consumption than conventional facilities because of their computing demands, advanced chips and greater cooling needs for AI workloads and training processes. According to an Arizton Advisory & Intelligence report, the U.S. data center market size is expected to reach $308.83 billion by 2030.

PPL’s Pennsylvania segment registered nearly 28.3 gigawatts (GW) of potential data center demand, up from 25.2 GW, with nearly 10 GW under signed electricity service agreements (ESAs) and 5 
GW already under construction.

In the Kentucky segment, the economic development pipeline now indicates potential load growth of 12.9 GW through 2032, up from the earlier estimate of 8.5 GW. The company received interest from 13 new data center projects, representing nearly 12 GW of active electricity demand.

PPL is undertaking substantial capital investments to upgrade its infrastructure and connect these data centers to the grid. It expects a regulated capital investment plan of $23 billion during 2026-2029. The company’s focus on generation, transmission and distribution projects, along with these investments, has helped improve service reliability and reduce customer outages.

Through these initiatives, PPL is strategically positioning itself to capitalize on the anticipated boom in the data center market. These efforts support new revenue streams and strengthen its long-term growth prospects.

Data Center Boom: A Growing Opportunity for UtilitiesThe rapid expansion of artificial intelligence and cloud computing is driving unprecedented data center electricity demand. This supports overall financial performance and creates a long-term growth opportunity for utilities. Other utilities that stand to benefit from the growing demand from data centers are as follows:

American Electric (AEP - Free Report) recognizes commercial load, driven particularly by energy-intensive sectors like AI-driven data centers. The company projects 63 GW of incremental contracted load by 2030, up from 56 GW previously, with hyperscale data centers contributing nearly 90% of demand.

Dominion Energy, Inc. (D - Free Report) is experiencing commercial load growth, driven by the demand from data centers. The company’s contracted data center capacity in Virginia rose to about 51 GW, increasing nearly 2.5 GW since December 2025.

PPL’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 EPS indicates a year-over-year increase of 7.73% and 8.21%, respectively.

Image Source: Zacks Investment Research

PPL Stock Trading at a PremiumPPL is trading at a premium relative to the industry, with a forward 12-month price-to-earnings of 17.55X compared with the industry average of 15.68X.

Image Source: Zacks Investment Research

PPL’s Stock Price PerformanceIn the past months, the company’s shares have plunged 6% compared with the industry’s 4.7% decline.

Image Source: Zacks Investment Research

PPL’s Zacks RankPPL currently has a Zacks Rank #4 (Sell). You can See the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

, /PRNewswire/ -- PPL Electric Utilities is pleased to report that, following the Pennsylvania Public Utility Commission's approval of its distribution rate case settlement with a minor modification, all parties to the joint settlement have reaffirmed their support and do not intend to withdraw.

The Company has submitted a letter to the rate case docket (R-2025-3057164) reflecting this continued support among stakeholders.

"We appreciate the parties' ongoing commitment to working constructively throughout this extensive review and for representing their constituents so effectively," said Christine Martin, President of PPL Electric Utilities. "As reflected in the Commission's decision, this settlement strikes an important balance by supporting affordability for customers while enabling the critical investments needed to serve our communities safely and reliably."

About PPL Electric Utilities
PPL Electric Utilities delivers safe, reliable and affordable electricity to 1.5 million homes and businesses in eastern and central Pennsylvania. It regularly ranks among the country's best utility companies for reliability and customer satisfaction. PPL Electric Utilities is a major employer and an active supporter of the communities it serves. It is a part of the PPL Corporation (NYSE: PPL) family of companies. Visit pplelectric.com or connect on social media via Facebook, Twitter and Instagram for energy efficiency tips, bill help information, guidance on shopping for an electricity supplier, storm updates and more.

Note to Editors: Visit our media website at https://news.pplweb.com/ for additional news and background about PPL Corporation. 

Contact: For news media: Dana Burns, [email protected], 610-774-5997
               PPL Electric Utilities

SOURCE PPL Electric Utilities

Key Takeaways PPL's new PA distribution rates start July 1, 2026, and are expected to add $275M a year. PPL says the added revenues support grid modernization and infrastructure tied to rising data-center demand.PPL plans $23B in regulated capex for 2026-2029 and targets 6-8% annual earnings growth through 2029. PPL Corporation (PPL - Free Report) is benefiting from the implementation of new rates across its regulated utility operations. This helps recover investments made in grid modernization and infrastructure upgrades while providing funding for ongoing capital investment programs. Higher rates boost revenues, strengthen cash flow and support earnings stability.

Recently, PPL Electric Utilities, the regulated electric distribution subsidiary of PPL, received approval from the Pennsylvania Public Utility Commission for new distribution rates effective July 1, 2026. Per the approval, new rates are expected to increase the company’s total revenues by $275 million annually.

This will help fund investments in transmission and distribution infrastructure, smart-grid technologies and vegetation management. The settlement also includes provisions to support low-income customers and establishes a new rate structure for large-load customers, such as data centers.

As part of the approved rate plan, PPL Electric Utilities will continue to offer flexible payment arrangements and energy-efficiency programs to help customers manage their electricity expenses. These measures include payment plans that allow customers to spread their bills over time, as well as tools and programs designed to reduce energy consumption through greater efficiency. This reflects the company's commitment to balancing infrastructure investments with customer affordability.

PPL projects a regulated capital investment of $23 billion during 2026-2029 and targets 6-8% annual earnings growth through 2029. The company’s systematic investments have helped to improve service reliability and reduce outages. The new rates will support these infrastructure investments by generating a stable revenue stream and helping achieve targeted earnings growth.

Utilities Benefit From Rate RevisionNo doubt, rate increases raise customers' utility bills, adding to their financial burden and pressure on household budgets. However, rate revisions are essential for maintaining and upgrading infrastructure and enabling utilities to efficiently serve growing customer demand.

In March 2026, American Water Works' (AWK - Free Report) unit, West Virginia American Water, received approval for new rates effective March 1, 2026. It is expected to generate nearly $20.5 million in additional annual revenues.

In January 2026, American States Water's (AWR - Free Report) unit, Golden State Water, received approval for second-year rate increases effective Jan. 1, 2026. It is expected to increase annual revenues by nearly $32 million.

PPL’s Earnings EstimatesThe Zacks Consensus Estimate for 2026 and 2027 earnings per share indicates an increase of 7.73% and 8.21%, respectively, year over year.

Image Source: Zacks Investment Research

Debt to CapitalPPL's debt-to-capital ratio currently stands at 57.40%, lower than the electric power industry’s 59.94%.

Image Source: Zacks Investment Research

PPL’s Stock Price PerformanceIn the past six months, the company’s shares have gained 5.9% compared with the industry’s 5.2% growth.

Image Source: Zacks Investment Research

PPL’s Zacks RankPPL currently has a Zacks Rank #4 (Sell). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Kinetik Holdings(KNTK +1.07%)delivers midstream infrastructure and services to oil and gas producers in the Texas Delaware Basin.

Zimmer Partners, LP disclosed a new stake in Kinetik Holdings in a February 17, 2026, SEC filing, acquiring 2,735,400 shares in the fourth quarter. The estimated transaction value is $98.61 million, based on quarterly average pricing.

What happenedAccording to a recent SEC filing dated February 17, 2026, Zimmer Partners, LP reported acquiring 2,735,400 shares of Kinetik Holdings during the fourth quarter. The estimated transaction value was $98.61 million, based on the quarter's average share price. The quarter-end position value also increased by $98.61 million, reflecting both share purchases and any price movement during the reporting period.

What else to knowThis was a new position for Zimmer Partners, LP, representing 2.6% of its $3.80 billion in 13F reportable AUM as of Dec. 31, 2025.

Top holdings after the filing:

NYSE:ES: $258.82 million (6.8% of AUM)NYSE:WELL: $207.28 million (5.5% of AUM)NASDAQ:XEL: $202.33 million (5.3% of AUM)NYSE:NI: $161.62 million (4.3% of AUM)NYSE:KGS: $159.76 million (4.2% of AUM)Company OverviewMetricValuePrice (as of market close 3/20/26)$45.93Market Capitalization$2.97 billionRevenue (TTM)$1.74 billionDividend Yield7.07%Company SnapshotProvides midstream services including gathering, transportation, compression, processing, and treating of natural gas, natural gas liquids, crude oil, and water.Operates midstream infrastructure in the Texas Delaware Basin, providing services to companies that produce natural gas, natural gas liquids, crude oil, and water.Provides services to companies that produce natural gas, natural gas liquids, crude oil, and water in the Texas Delaware Basin.Kinetik Holdings is a leading midstream energy company with a significant presence in the Texas Delaware Basin, serving as a critical infrastructure provider for the region's oil and gas producers. The company leverages its integrated asset base and long-term customer contracts to maintain stable cash flows and a competitive dividend yield. Its strategic focus on essential midstream services positions it as a key partner for upstream operators seeking reliable transportation and processing solutions.

What this transaction means for investorsZimmer Partners, a New York-based investment firm, recently disclosed a fourth-quarter (the three months ending on Dec. 31, 2025) purchase of nearly $99 million worth of Kinetik Holdings, an energy stock. Here are some key takeaways for investors.

Kinetik is a midstream energy company. It provides the intermediary processes that help turn raw natural gas and crude oil into the fuels that end consumers use to power vehicles, factories, and homes.

Recent reports suggest Kinetik could be a takeover target. According to reports, Kinetik is considering a sale to Western Midstream. Shares of Kinetik are up 27% year to date.

The recent spike in energy prices may have many retail investors pondering energy stocks. One way to gain exposure to the sector is through a diversified exchange-traded fund (ETF). The State Street Energy Select Sector SPDR ETF(XLE +0.99%), for example, offers broad-based exposure and charges only 0.08% in fees.